New! Sign up for our free email newsletter.
Reference Terms
from Wikipedia, the free encyclopedia

Bitemporal hemianopsia

Bitemporal hemianopsia (or Bitemporal hemianopia) is the medical description of a type of partial blindness where vision is missing in the outer half of both the right and left visual field. It is usually associated with lesions of the optic chiasm, the area where the optic nerves from the right and left eyes cross near the pituitary gland.

In bitemporal hemianopsia vision is missing in the outer (temporal or lateral) half of both the right and left visual fields. Information from the temporal visual field falls on the nasal (medial) retina. The nasal retina is responsible for carrying the information along the optic nerve, and crosses to the other side at the optic chiasm. When there is compression at optic chiasm the visual impulse from both nasal retina are affected, leading to inability to view the temporal, or peripheral, vision. This phenomenon is known as bitemporal hemianopsia. Knowing the neurocircuitry of visual signal flow through the optic tract is very important in understanding bitemporal hemianopsia.

Bitemporal hemianopsia most commonly occurs as a result of tumors located at the mid-optic chiasm. Since the adjacent structure is the pituitary gland, some common tumors causing compression are Pituitary adenomas, and Craniopharyngiomas. Also another relatively common neoplastic etiology is Meningiomas.

The absence of vision in half of a visual field is described as hemianopsia.

The visual field of each eye can be divided in two vertically, with the outer half being described as temporal, and the inner half being described as nasal.

"Bitemporal hemianopsia" can be broken down as follows:

bi-: involves both left and right visual fields

temporal: involves the temporal visual field

hemi-: involves half of each visual field

anopsia: blindness

Related Stories
 


Health & Medicine News

May 6, 2026

A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal cancer. Patients in a UK-led trial who received just nine weeks of pembrolizumab prior to surgery have remained cancer-free ...
A major 10-year clinical trial is turning one of the world’s most common knee surgeries on its head. Researchers found that trimming a damaged meniscus—a procedure long believed to relieve pain—offers no real benefit over placebo surgery. Even ...
A chaotic sleep schedule in your 40s might be quietly setting the stage for heart trouble later. Researchers tracking thousands of people for over a decade found that those with highly inconsistent bedtimes—especially when they slept less than ...
Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue from within, reducing inflammation and jumpstarting healing. In animal studies, it successfully treated heart attack damage ...
GLP-1 weight-loss drugs like Ozempic and Wegovy are often celebrated as game-changing solutions—but new research reveals a surprising social twist. People who lose weight using these medications may actually face more judgment than those who lose ...
A new study suggests travel could be a surprisingly powerful anti-aging tool. By viewing tourism through the lens of entropy, researchers found that positive travel experiences may help the body stay balanced and resilient. Activities like exploring ...
A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of toxic amyloid proteins in the brain, a ...
For decades, relaxor ferroelectrics have powered everything from medical ultrasounds to sonar systems, yet their inner atomic structure remained a mystery—until now. Researchers have finally mapped ...
Creatine might be famous in the gym, but its real story is far more interesting. Naturally produced in the body, it helps power cells by rapidly regenerating ATP—the fuel that keeps muscles, the brain, and even the heart running during intense ...
A new study suggests depression may soon be detectable through a simple blood test—by tracking how certain immune cells age. Researchers found that accelerated aging in monocytes, a type of white blood cell, is closely tied to the emotional and ...
GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In a massive study tracking nearly 100,000 people over more than a ...
Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review of over 20,000 participants. Even more concerning, they ...

Latest Headlines

updated 12:56 pm ET